Skip to Main Content
Division of Infectious Diseases

Research

Back to search

Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial

Date:

12/15/2023

Topics:

Citation:

Desai NM, Leung SG, Motter JD, Segev DL, Warren D, Durand CM. Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial. Ann Intern Med. 2023 Dec;176(12):1682-1684. doi: 10.7326/M23-2682. Epub 2023 Nov 28. PMID: 38011702.

Abstract

No abstract available

View Full Research Publication

https://pubmed.ncbi.nlm.nih.gov/38011702/